Description of the pharmaceuti...
2024/1/25 5:25:06
The opportunities for pharmaceutical intermediates to enter crowded markets are relatively limited, and the market entry threshold has also been raised. In order for new drugs to gain a foothold in the schizophrenia treatment market, they must have distinctive features and novel effects compared to existing drugs,
There are a large number of patients with diverse needs, and existing drugs have not yet been able to meet the huge treatment needs. Especially, there will be more opportunities for drugs used to treat negative symptoms of schizophrenia, because about two-thirds of schizophrenia patients will experience obvious negative symptoms, and existing drugs do not control these symptoms well.
Pharmaceutical intermediates are directly related to human health and life safety, and are one of the four key technological innovation industries in China. They are also a special industry with high technology intensity, high investment, good benefits, long cycles, and high risks. However, due to various unreasonable factors in the production and distribution sectors, the order of drug production and operation in China is chaotic, and corrupt practices such as bribery, solicitation of bribes, and kickbacks are prevalent in drug purchase and sales. It is difficult to regulate market behavior from the perspective of laws and regulations.